Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.990
-0.140 (-6.57%)
At close: Jul 18, 2025, 4:00 PM
2.030
+0.040 (2.01%)
After-hours: Jul 18, 2025, 6:11 PM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $74.39 million as of July 18, 2025. Its market cap has decreased by -55.08% in one year.
Market Cap
74.39M
Enterprise Value
-102.66M
1-Year Change
-55.08%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $74.39M, a decrease of -86.79%. That is a compound annual growth rate of -75.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 79.62M | -41.06% |
| Dec 31, 2024 | 135.10M | -76.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.50B |
| Johnson & Johnson | 395.34B |
| AbbVie | 335.00B |
| Novo Nordisk | 292.40B |
| UnitedHealth Group | 257.36B |
| Novartis AG | 224.54B |
| Abbott Laboratories | 216.66B |
| AstraZeneca | 214.46B |